Abiopharma

🔍 SEIDMAN LAWRENCE B (Director)

Company: Bankwell Financial Group, Inc. (BWFG)

Report Date: 2026-08-25

Detailed Transactions and Holdings:

• Acquired 994 shares of Common Stock at $65.89 per share (Direct)
  Date: 2026-08-25 | Code: P | equity_swap_involved: 0 | shares_owned_after: 223,684.00 | transaction_form_type: 4
• Acquired 259 shares of Common Stock at $65.94 per share (Direct)
  Date: 2026-08-25 | Code: P | equity_swap_involved: 0 | shares_owned_after: 142,338.00 | transaction_form_type: 4
• Acquired 219 shares of Common Stock at $65.96 per share (Direct)
  Date: 2026-08-25 | Code: P | equity_swap_involved: 0 | shares_owned_after: 178,352.00 | transaction_form_type: 4
• Acquired 662 shares of Common Stock at $65.9 per share (Direct)
  Date: 2026-08-25 | Code: P | equity_swap_involved: 0 | shares_owned_after: 131,970.00 | transaction_form_type: 4
• Acquired 262 shares of Common Stock at $65.94 per share (Direct)
  Date: 2026-08-25 | Code: P | equity_swap_involved: 0 | shares_owned_after: 136,738.00 | transaction_form_type: 4
• Acquired 144 shares of Common Stock at $66.01 per share (Direct)
  Date: 2026-08-25 | Code: P | equity_swap_involved: 0 | shares_owned_after: 25,321.00 | transaction_form_type: 4
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-08-25 | Code: H | shares_owned_after: 17,463.00
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-08-25 | Code: H | shares_owned_after: 1,455.00 | Footnotes: F1
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-08-25 | Code: H | shares_owned_after: 1,200.00 | Footnotes: F2
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-08-25 | Code: H | shares_owned_after: 534.00 | Footnotes: F3
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-08-25 | Code: H | shares_owned_after: 400.00 | Footnotes: F4
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-08-25 | Code: H | nature_of_ownership: Deferred Compensation Plan | shares_owned_after: 4,844.00

Footnotes:

• F1: 1,455 shares of restricted stock granted on February 9, 2026, pursuant to the 2022 Bankwell Financial Group, Inc. Stock Plan with 485 to vest on February 7, 2027. 485 will vest on February 7, 2028 and 485 will vest on February 7, 2029.
• F2: 1,800 shares of restricted stock granted on February 7, 2025, pursuant to the 2022 Bankwell Financial Group, Inc. Stock Plan with 600 to vest on February 7, 2026. 600 will vest on February 7, 2027 and 600 will vest on February 7, 2028. As of the filing date, 600 shares have vested.
• F3: 1,600 shares of restricted stock granted on December 29, 2023, pursuant to the 2022 Bankwell Financial Group, Inc. Stock Plan with 533 vested on February 7, 2025, 533 will vest on February 7, 2026 and 534 will vest on February 7, 2027. As of the filing date, 1,066 shares have vested.
• F4: 1,600 shares of restricted stock granted on December 30, 2022, pursuant to the 2012 Bankwell Financial Group, Inc. Stock Plan and will vest in four equal annual installments of 25%, with the first installment vesting on January 2, 2024 and an additional 25% to vest on each annual anniversary of the vesting date thereafter. As of the filing date, 1,200 shares have vested.